138 results on '"Holčapek M"'
Search Results
2. High-performance liquid chromatography–tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites
3. Validated HPLC–MS/MS method for determination of quetiapine in human plasma
4. A structure of fuzzy systems for support of decision making
5. High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma
6. Disposition study of a new potential antineoplastic agent dimefluron in rats using high-performance liquid chromatography with ultraviolet and mass spectrometric detection
7. Identification and determination of phase II nabumetone metabolites by high-performance liquid chromatography with photodiode array and mass spectrometric detection
8. Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection
9. 27Al, 15N, 13C and 1H NMR spectra and negative-ion electrospray mass spectra of the 2:1 aluminium(III) complexes of azo dyes derived from anthranilic acid
10. Weak boundary value problem: Fuzzy partition in Galerkin method
11. NON-PARAMETRIC REGRESSION USING DISCRETE HIGHER DEGREE F-TRANSFORM
12. Mass spectrometry: Innovation and application—Part VIII
13. TREND-CYCLE ESTIMATION USING FUZZY TRANSFORM OF HIGHER DEGREE.
14. Plasma and erythrocyte fatty acid analysis in cardiovascular diseases
15. Mass spectrometry: Innovation and application. Part VII
16. Mass spectrometry: Innovation and application. Part VI
17. Electrochemical treatment of a simple azodye and analysis of the degradation products using high performance liquid chromatography-diode array detection-tandem mass spectrometry
18. Erratum to “High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma” [J. Chromatogr. A 1119 (2006) 299–308]
19. Corrigendum to “Disposition study of a new potential antineoplastic agent dimefluron in rats using high-performance liquid chromatography with ultraviolet and mass spectrometric detection” [J. Pharm. Biomed. Anal. 37 (2005) 1059–1071]
20. Effects of ion-pairing reagents on the electrospray signal suppression of sulphonated dyes and intermediates
21. Trace Determination of Glycols by HPLC with UV and Electrospray Ionization Mass Spectrometric Detections
22. Plasma samples lipidomická characterization cardiovascular diseases,Lipidomická charakterizace vzorků plazmy pacientů s kardiovaskulárními chorobami
23. Alternative approach to density function estimations
24. Analysis of natural mixtures of triacylglycerols using HPLC/MS technique,Analýza přírodních směsí triacylglycerolů technikou HPLC/MS
25. Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards.
26. New trends in lipidomics.
27. Unraveling the complexity of glycosphingolipidome: the key role of mass spectrometry in the structural analysis of glycosphingolipids.
28. The lipidomics reporting checklist a framework for transparency of lipidomic experiments and repurposing resource data.
29. Ultrahigh-Performance Supercritical Fluid Chromatography-Mass Spectrometry in the Clinical Lipidomic Analysis.
30. Reversed-Phase Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Method for High-Throughput Lipidomic Quantitation.
31. HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer.
32. Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination.
33. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
34. Robust and high-throughput lipidomic quantitation of human blood samples using flow injection analysis with tandem mass spectrometry for clinical use.
35. Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma.
36. Liquid chromatography at the University of Pardubice: A tribute to Professor Pavel Jandera.
37. Commemorating Pavel Jandera - Editorial.
38. Introducing the Lipidomics Minimal Reporting Checklist.
39. Ultrahigh-performance supercritical fluid chromatography - mass spectrometry for the qualitative analysis of metabolites covering a large polarity range.
40. Clinical lipidomics - A community-driven roadmap to translate research into clinical applications.
41. Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues.
42. Lipidomic profiling of human serum enables detection of pancreatic cancer.
43. Retention dependences support highly confident identification of lipid species in human plasma by reversed-phase UHPLC/MS.
44. Corrigendum to: LipidQuant 1.0: automated data processing in lipid class separation-mass spectrometry quantitative workflows.
45. LipidQuant 1.0: automated data processing in lipid class separation-mass spectrometry quantitative workflows.
46. Simple and Reproducible Derivatization with Benzoyl Chloride: Improvement of Sensitivity for Multiple Lipid Classes in RP-UHPLC/MS.
47. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.
48. Multiomics of synaptic junctions reveals altered lipid metabolism and signaling following environmental enrichment.
49. In memory of Pavel Jandera.
50. Intra-laboratory comparison of four analytical platforms for lipidomic quantitation using hydrophilic interaction liquid chromatography or supercritical fluid chromatography coupled to quadrupole - time-of-flight mass spectrometry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.